Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.75
Delayed Data
As of May 25
 +0.45 / +5.42%
Today’s Change
5.21
Today|||52-Week Range
30.13
-13.02%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.30
Today’s open8.36
Day’s range8.29 - 8.99
Volume621,040
Average volume (3 months)882,556
Market cap$283.0M
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-25.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.23+2.83%
LBIOLion Biotechnologies...+0.20+3.49%
CRVSCorvus Pharmaceutica...+0.02+0.14%
ARDXArdelyx Inc+0.42+5.01%
Data as of 05/25/2016

Financials

Next reporting dateJune 13, 2016
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, Director &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs